FDB-led panel will discuss how they are advancing CDS in their institutions to deliver more personalized and actionable guidance to…
The collaboration delivers greater value to clients for seamless data exchange, enhanced continuity of care, and improved clinical outcomes.CHELMSFORD, MA…
Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding…
BRECKENRIDGE, Colo., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S. and a…
Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29,…
Interoperability is a team sport, and Epic looks forward to Oracle Health getting off the sidelines and joining the game.…
INDIANAPOLIS, IN / ACCESSWIRE / October 28, 2024 / 3Aware, a pioneer in real-world evidence (RWE) solutions for the medical…
New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months1Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate…
Statistically significant 68% (p<0.0001) proteinuria reduction compared to placebo, with reduction observed as early as Week 4 All secondary endpoints…
SAN FRANCISCO, Oct. 25, 2024 /PRNewswire/ -- Hospital quality reporting platform Pharos announced today the close of its oversubscribed $5M seed round led…